Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome

Angela E. Lin, Mark E. Alexander, Steven D. Colan, Bronwyn Kerr, Katherine A. Rauen, Jacqueline Noonan, Jeanne Baffa, Elizabeth Hopkins, Katia Sol-Church, Giuseppe Limongelli, Maria Christina Digilio, Bruno Marino, A. Micheil Innes, Yoko Aoki, Gary (Michael) Silberbach, Marie Ange Delrue, Susan M. White, Robert M. Hamilton, William O'Connor, Paul D. GrossfeldLeslie B. Smoot, Robert F. Padera, Karen W. Gripp

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Cardiovascular abnormalities are important features of Costello syndrome and other Ras/MAPK pathway syndromes ("RASopathies"). We conducted clinical, pathological and molecular analyses of 146 patients with an HRAS mutation including 61 enrolled in an ongoing longitudinal study and 85 from the literature. In our study, the most common (84%) HRAS mutation was p.G12S. A congenital heart defect (CHD) was present in 27 of 61 patients (44%), usually non-progressive valvar pulmonary stenosis. Hypertrophic cardiomyopathy (HCM), typically subaortic septal hypertrophy, was noted in 37 (61%), and 5 also had a CHD (14% of those with HCM). HCM was chronic or progressive in 14 (37%), stabilized in 10 (27%), and resolved in 5 (15%) patients with HCM; follow-up data was not available in 8 (22%). Atrial tachycardia occurred in 29 (48%). Valvar pulmonary stenosis rarely progressed and atrial septal defect was uncommon. Among those with HCM, the likelihood of progressing or remaining stable was similar (37%, 41% respectively). The observation of myocardial fiber disarray in 7 of 10 (70%) genotyped specimens with Costello syndrome is consistent with sarcomeric dysfunction. Multifocal atrial tachycardia may be distinctive for Costello syndrome. Potentially serious atrial tachycardia may present in the fetus, and may continue or worsen in about one-fourth of those with arrhythmia, but is generally self-limited in the remaining three-fourths of patients. Physicians should be aware of the potential for rapid development of severe HCM in infants with Costello syndrome, and the need for cardiovascular surveillance into adulthood as the natural history continues to be delineated.

Original languageEnglish (US)
Pages (from-to)486-507
Number of pages22
JournalAmerican Journal of Medical Genetics, Part A
Volume155
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Costello Syndrome
Cardiovascular Abnormalities
Hypertrophic Cardiomyopathy
Tachycardia
Pulmonary Valve Stenosis
Congenital Heart Defects
Mutation
Atrial Heart Septal Defects
Natural History
Hypertrophy
Longitudinal Studies
Cardiac Arrhythmias
Fetus
Observation
Physicians

Keywords

  • Aortic dilation
  • Arrhythmias
  • Cardiovascular malformation
  • Chaotic atrial rhythm
  • Congenital heart defect
  • Ectopic atrial tachycardia
  • HRAS
  • Hypertrophic cardiomyopathy
  • Multifocal atrial tachycardia
  • Noonan-spectrum syndromes
  • RASopathy

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome : A Ras/MAPK pathway syndrome. / Lin, Angela E.; Alexander, Mark E.; Colan, Steven D.; Kerr, Bronwyn; Rauen, Katherine A.; Noonan, Jacqueline; Baffa, Jeanne; Hopkins, Elizabeth; Sol-Church, Katia; Limongelli, Giuseppe; Digilio, Maria Christina; Marino, Bruno; Innes, A. Micheil; Aoki, Yoko; Silberbach, Gary (Michael); Delrue, Marie Ange; White, Susan M.; Hamilton, Robert M.; O'Connor, William; Grossfeld, Paul D.; Smoot, Leslie B.; Padera, Robert F.; Gripp, Karen W.

In: American Journal of Medical Genetics, Part A, Vol. 155, No. 3, 03.2011, p. 486-507.

Research output: Contribution to journalArticle

Lin, AE, Alexander, ME, Colan, SD, Kerr, B, Rauen, KA, Noonan, J, Baffa, J, Hopkins, E, Sol-Church, K, Limongelli, G, Digilio, MC, Marino, B, Innes, AM, Aoki, Y, Silberbach, GM, Delrue, MA, White, SM, Hamilton, RM, O'Connor, W, Grossfeld, PD, Smoot, LB, Padera, RF & Gripp, KW 2011, 'Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome', American Journal of Medical Genetics, Part A, vol. 155, no. 3, pp. 486-507. https://doi.org/10.1002/ajmg.a.33857
Lin, Angela E. ; Alexander, Mark E. ; Colan, Steven D. ; Kerr, Bronwyn ; Rauen, Katherine A. ; Noonan, Jacqueline ; Baffa, Jeanne ; Hopkins, Elizabeth ; Sol-Church, Katia ; Limongelli, Giuseppe ; Digilio, Maria Christina ; Marino, Bruno ; Innes, A. Micheil ; Aoki, Yoko ; Silberbach, Gary (Michael) ; Delrue, Marie Ange ; White, Susan M. ; Hamilton, Robert M. ; O'Connor, William ; Grossfeld, Paul D. ; Smoot, Leslie B. ; Padera, Robert F. ; Gripp, Karen W. / Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome : A Ras/MAPK pathway syndrome. In: American Journal of Medical Genetics, Part A. 2011 ; Vol. 155, No. 3. pp. 486-507.
@article{8265cc0208ea446f9c0eda7df1ea0a92,
title = "Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome",
abstract = "Cardiovascular abnormalities are important features of Costello syndrome and other Ras/MAPK pathway syndromes ({"}RASopathies{"}). We conducted clinical, pathological and molecular analyses of 146 patients with an HRAS mutation including 61 enrolled in an ongoing longitudinal study and 85 from the literature. In our study, the most common (84{\%}) HRAS mutation was p.G12S. A congenital heart defect (CHD) was present in 27 of 61 patients (44{\%}), usually non-progressive valvar pulmonary stenosis. Hypertrophic cardiomyopathy (HCM), typically subaortic septal hypertrophy, was noted in 37 (61{\%}), and 5 also had a CHD (14{\%} of those with HCM). HCM was chronic or progressive in 14 (37{\%}), stabilized in 10 (27{\%}), and resolved in 5 (15{\%}) patients with HCM; follow-up data was not available in 8 (22{\%}). Atrial tachycardia occurred in 29 (48{\%}). Valvar pulmonary stenosis rarely progressed and atrial septal defect was uncommon. Among those with HCM, the likelihood of progressing or remaining stable was similar (37{\%}, 41{\%} respectively). The observation of myocardial fiber disarray in 7 of 10 (70{\%}) genotyped specimens with Costello syndrome is consistent with sarcomeric dysfunction. Multifocal atrial tachycardia may be distinctive for Costello syndrome. Potentially serious atrial tachycardia may present in the fetus, and may continue or worsen in about one-fourth of those with arrhythmia, but is generally self-limited in the remaining three-fourths of patients. Physicians should be aware of the potential for rapid development of severe HCM in infants with Costello syndrome, and the need for cardiovascular surveillance into adulthood as the natural history continues to be delineated.",
keywords = "Aortic dilation, Arrhythmias, Cardiovascular malformation, Chaotic atrial rhythm, Congenital heart defect, Ectopic atrial tachycardia, HRAS, Hypertrophic cardiomyopathy, Multifocal atrial tachycardia, Noonan-spectrum syndromes, RASopathy",
author = "Lin, {Angela E.} and Alexander, {Mark E.} and Colan, {Steven D.} and Bronwyn Kerr and Rauen, {Katherine A.} and Jacqueline Noonan and Jeanne Baffa and Elizabeth Hopkins and Katia Sol-Church and Giuseppe Limongelli and Digilio, {Maria Christina} and Bruno Marino and Innes, {A. Micheil} and Yoko Aoki and Silberbach, {Gary (Michael)} and Delrue, {Marie Ange} and White, {Susan M.} and Hamilton, {Robert M.} and William O'Connor and Grossfeld, {Paul D.} and Smoot, {Leslie B.} and Padera, {Robert F.} and Gripp, {Karen W.}",
year = "2011",
month = "3",
doi = "10.1002/ajmg.a.33857",
language = "English (US)",
volume = "155",
pages = "486--507",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome

T2 - A Ras/MAPK pathway syndrome

AU - Lin, Angela E.

AU - Alexander, Mark E.

AU - Colan, Steven D.

AU - Kerr, Bronwyn

AU - Rauen, Katherine A.

AU - Noonan, Jacqueline

AU - Baffa, Jeanne

AU - Hopkins, Elizabeth

AU - Sol-Church, Katia

AU - Limongelli, Giuseppe

AU - Digilio, Maria Christina

AU - Marino, Bruno

AU - Innes, A. Micheil

AU - Aoki, Yoko

AU - Silberbach, Gary (Michael)

AU - Delrue, Marie Ange

AU - White, Susan M.

AU - Hamilton, Robert M.

AU - O'Connor, William

AU - Grossfeld, Paul D.

AU - Smoot, Leslie B.

AU - Padera, Robert F.

AU - Gripp, Karen W.

PY - 2011/3

Y1 - 2011/3

N2 - Cardiovascular abnormalities are important features of Costello syndrome and other Ras/MAPK pathway syndromes ("RASopathies"). We conducted clinical, pathological and molecular analyses of 146 patients with an HRAS mutation including 61 enrolled in an ongoing longitudinal study and 85 from the literature. In our study, the most common (84%) HRAS mutation was p.G12S. A congenital heart defect (CHD) was present in 27 of 61 patients (44%), usually non-progressive valvar pulmonary stenosis. Hypertrophic cardiomyopathy (HCM), typically subaortic septal hypertrophy, was noted in 37 (61%), and 5 also had a CHD (14% of those with HCM). HCM was chronic or progressive in 14 (37%), stabilized in 10 (27%), and resolved in 5 (15%) patients with HCM; follow-up data was not available in 8 (22%). Atrial tachycardia occurred in 29 (48%). Valvar pulmonary stenosis rarely progressed and atrial septal defect was uncommon. Among those with HCM, the likelihood of progressing or remaining stable was similar (37%, 41% respectively). The observation of myocardial fiber disarray in 7 of 10 (70%) genotyped specimens with Costello syndrome is consistent with sarcomeric dysfunction. Multifocal atrial tachycardia may be distinctive for Costello syndrome. Potentially serious atrial tachycardia may present in the fetus, and may continue or worsen in about one-fourth of those with arrhythmia, but is generally self-limited in the remaining three-fourths of patients. Physicians should be aware of the potential for rapid development of severe HCM in infants with Costello syndrome, and the need for cardiovascular surveillance into adulthood as the natural history continues to be delineated.

AB - Cardiovascular abnormalities are important features of Costello syndrome and other Ras/MAPK pathway syndromes ("RASopathies"). We conducted clinical, pathological and molecular analyses of 146 patients with an HRAS mutation including 61 enrolled in an ongoing longitudinal study and 85 from the literature. In our study, the most common (84%) HRAS mutation was p.G12S. A congenital heart defect (CHD) was present in 27 of 61 patients (44%), usually non-progressive valvar pulmonary stenosis. Hypertrophic cardiomyopathy (HCM), typically subaortic septal hypertrophy, was noted in 37 (61%), and 5 also had a CHD (14% of those with HCM). HCM was chronic or progressive in 14 (37%), stabilized in 10 (27%), and resolved in 5 (15%) patients with HCM; follow-up data was not available in 8 (22%). Atrial tachycardia occurred in 29 (48%). Valvar pulmonary stenosis rarely progressed and atrial septal defect was uncommon. Among those with HCM, the likelihood of progressing or remaining stable was similar (37%, 41% respectively). The observation of myocardial fiber disarray in 7 of 10 (70%) genotyped specimens with Costello syndrome is consistent with sarcomeric dysfunction. Multifocal atrial tachycardia may be distinctive for Costello syndrome. Potentially serious atrial tachycardia may present in the fetus, and may continue or worsen in about one-fourth of those with arrhythmia, but is generally self-limited in the remaining three-fourths of patients. Physicians should be aware of the potential for rapid development of severe HCM in infants with Costello syndrome, and the need for cardiovascular surveillance into adulthood as the natural history continues to be delineated.

KW - Aortic dilation

KW - Arrhythmias

KW - Cardiovascular malformation

KW - Chaotic atrial rhythm

KW - Congenital heart defect

KW - Ectopic atrial tachycardia

KW - HRAS

KW - Hypertrophic cardiomyopathy

KW - Multifocal atrial tachycardia

KW - Noonan-spectrum syndromes

KW - RASopathy

UR - http://www.scopus.com/inward/record.url?scp=79952017072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952017072&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33857

DO - 10.1002/ajmg.a.33857

M3 - Article

C2 - 21344638

AN - SCOPUS:79952017072

VL - 155

SP - 486

EP - 507

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -